Lord, Abbett & Co’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $60M | Buy |
3,581,639
+811,519
| +29% | +$13.6M | 0.19% | 135 |
|
|
2025
Q1 | $42.6M | Buy |
2,770,120
+365,225
| +15% | +$5.61M | 0.15% | 169 |
|
|
2024
Q4 | $53M | Buy |
2,404,895
+960,648
| +67% | +$21.2M | 0.17% | 159 |
|
|
2024
Q3 | $26M | Sell |
1,444,247
-188,753
| -12% | -$3.4M | 0.08% | 282 |
|
|
2024
Q2 | $26.5M | Buy |
+1,633,000
| New | +$26.5M | 0.09% | 276 |
|
|
2016
Q4 | – | Sell |
-48,757
| Closed | -$2.24M | – | 955 |
|
|
2016
Q3 | $2.24M | Sell |
48,757
-37,666
| -44% | -$1.73M | 0.01% | 825 |
|
|
2016
Q2 | $4.34M | Sell |
86,423
-367
| -0.4% | -$18.4K | 0.01% | 741 |
|
|
2016
Q1 | $4.64M | Sell |
86,790
-91,509
| -51% | -$4.9M | 0.01% | 722 |
|
|
2015
Q4 | $11.7M | Buy |
178,299
+6,386
| +4% | +$419K | 0.04% | 558 |
|
|
2015
Q3 | $9.71M | Buy |
+171,913
| New | +$9.71M | 0.03% | 594 |
|
|
2014
Q4 | – | Sell |
-213,000
| Closed | -$11.4M | – | 977 |
|
|
2014
Q3 | $11.4M | Sell |
213,000
-74,200
| -26% | -$3.99M | 0.03% | 580 |
|
|
2014
Q2 | $15.1M | Buy |
287,200
+16,000
| +6% | +$839K | 0.03% | 564 |
|
|
2014
Q1 | $14.3M | Buy |
+271,200
| New | +$14.3M | 0.03% | 550 |
|